Cancer Gene Therapy
Novel Program Underway to Increase Participation in Clinical Trials
Published in Cancer Weekly, October 2nd, 2007
Before a new treatment for a disease like cancer becomes available, physician-researchers must recruit hundreds or thousands of patients to participate in clinical research trials. Yet, too often, finding these patients is difficult, as individuals may be unaware of clinical studies, or logistical barriers may preclude participation. The result is that many patients miss out on opportunities for novel treatment approaches, and the development of new and improved therapies is delayed.
Addressing this vital issue is a unique and innovative collaborative study, known as IMPACT, for "Improving Methods for Patient Accrual to Clinical Trials." Two institutions -- Weill...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2007-10-02)
More Articles from Cancer Weekly
- Cancer Gene Therapy
T vs. B: Re-engineered Human T Cells Effectively Target and Kill Cancerous B Cells - Cancer Vaccines
HPV’s Link to Head and Neck Cancer Investigated at Vanderbilt-Ingram - Cancer Vaccines
M.D. Anderson-led team reports possible key to autoimmune disease - Biomedicine
Carnegie Mellon Establishes Ray and Stephanie Lane Center for Computational Biology - Breast Cancer
'Are You Man Enough?' to Help Fight Breast Cancer - Breast Cancer
AstraZeneca Launches New Virtual Fund-Raising Activity to Honor Breast Cancer Survivors - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
